Page 1 of Clinical Trials for fluticasone salmeterol, 186 Total Matches
- 1CompletedLast Updated: March 17, 2011Condition(s): Asthma
- 2Not yet recruitingLast Updated: September 9, 2009Condition(s): Chronic Obstructive Pulmonary Disease; Depression
- 3WithdrawnLast Updated: February 29, 2012Condition(s): Chronic Obstructive Pulmonary Disease; Sleep Disorders
- 4RecruitingLast Updated: March 23, 2009Condition(s): Asthma
- 5Completed
- 6Not yet recruitingLast Updated: August 8, 2008Condition(s): COPD
- 7CompletedLast Updated: June 16, 2011Condition(s): Chronic Obstructive Pulmonary Disease (COPD)
- 8CompletedLast Updated: February 24, 2010Condition(s): Asthma
- 9RecruitingLast Updated: May 10, 2012Condition(s): Asthma
- 10CompletedLast Updated: December 16, 2010Condition(s): CV Risk; Pulmonary Disease, Chronic Obstructive; Chronic Bronchitis; Chronic Obstructive Pulmonary Disease (COPD); Cardiovascular Disease; Smoking; Emphysema
- 11Completed
- 12RecruitingLast Updated: April 16, 2007Condition(s): Asthma
- 13CompletedLast Updated: March 15, 2012Condition(s): Pulmonary Disease, Chronic Obstructive
- 14Completed
- 15Recruiting
- 16RecruitingLast Updated: May 8, 2006Condition(s): Chronic Obstructive Pulmonary Disease
- 17Active, not recruitingLast Updated: January 30, 2006Condition(s): Asthma; Candidiasis, Oral; Voice Disorders
- 18Active, not recruitingLast Updated: February 2, 2012Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease
- 19Completed
- 20CompletedLast Updated: May 17, 2012Condition(s): Pulmonary Disease, Chronic Obstructive
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=fluticasone+salmeterol
